Mirae Asset Global Investments Co., Ltd.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1569395 SEOUL, M5

Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$303,124

+$37,996 QoQ

Shares Held

8,947

+5.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 164 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $20,006,890 across 33 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	108,368	$7,787,323
2	VTRS	Viatris Inc	305,332	$4,848,671
3	UTHR	UNITED THERAPEUTICS Corp	4,119	$2,231,797
4	NBIX	Neurocrine Biosciences Inc	9,700	$1,634,837
5	ELAN	Elanco Animal Health Inc	23,364	$574,988
6	ALKS	Alkermes plc.	7,454	$390,552
7	KNSA	Kiniksa Pharmaceuticals International, plc	5,982	$382,548
8	TEVA	Teva Pharmaceutical Industries Ltd This page	8,947	$303,124

All Filings in TEVA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$303,124	8,947	+5.3%	Shares	Sole	2026-07-22
2025-12-31	$265,128	8,495	+10.2%	Shares	Sole	2026-01-26
2025-09-30	$155,681	7,707	+40.8%	Shares	Sole	2025-11-03
2025-06-30	$91,744	5,474	+15.0%	Shares	Sole	2025-07-21
2025-03-31	$73,145	4,759	+4.5%	Shares	Sole	2025-04-24
2024-12-31	$100,326	4,552	0.0%	Shares	Sole	2025-01-27
2024-09-30	$82,027	4,552	+3.3%	Shares	Sole	2024-10-23
2024-06-30	$71,597	4,406	—	Shares	Sole	2024-07-30
No filing history on record for this holder in this stock.